Neurologia medico-chirurgica
Online ISSN : 1349-8029
Print ISSN : 0470-8105
ISSN-L : 0470-8105
Search
Advanced search
OR
Browse
Search
Volume 55, Issue 2
Displaying 1-12 of 12 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Review Articles
  • Stem Cell Transplantation Enhances Endogenous Brain Repair after Experimental Stroke
    Nobutaka HORIE, Takeshi HIU, Izumi NAGATA
    2015 Volume 55 Issue 2 Pages 107-112
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.ra.2014-0271
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    Stem cell transplantation for stroke treatment has been a promising therapy in small and large animal models, and many clinical trials are ongoing to establish this strategy in a clinical setting. However, the mechanism underlying functional recovery after stem cell transplantation has not been fully established and there is still a need to determine the ideal subset of stem cells for such therapy. We herein reviewed the recent evidences showing the underlying mechanism of functional recovery after cell transplantation, focusing on endogenous brain repair. First, angiogenesis/neovascularization is promoted by trophic factors including vascular endothelial growth factor secreted from stem cells, and stem cells migrated to the lesion along with the vessels. Second, axonal sprouting, dendritic branching, and synaptogenesis were enhanced altogether in the both ipsilateral and contralateral hemisphere remapping the pyramidal tract across the board. Finally, endogenous neurogenesis was also enhanced although little is known how much these neurogenesis contribute to the functional recovery. Taken together, it is clear that stem cell transplantation provides functional recovery via endogenous repair enhancement from multiple ways. This is important to maximize the effect of stem cell therapy after stroke, although it is still undetermined which repair mechanism is mostly contributed.
    View full abstract
    Download PDF (1067K)
  • Regenerative Medicine for Parkinson’s Disease
    Takao YASUHARA, Masahiro KAMEDA, Takashi AGARI, Isao DATE
    2015 Volume 55 Issue 2 Pages 113-123
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.ra.2014-0264
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    Regenerative medicine for Parkinson’s disease (PD) is expected to develop dramatically with the advancement of biotechnology as represented by induced pluripotent stem cells. Existing therapeutic strategy for PD consists of medication using L-DOPA, surgery such as deep brain stimulation and rehabilitation. Current treatment cannot stop the progression of the disease, although there is definite therapeutic effect. True neurorestoration is strongly desired by regenerative medicine. This review article describes the historical development of regenerative medicine for PD, with a focus on fetal nigral cell transplantation and glial cell line-derived neurotrophic factor infusion. Subsequently, the current status of regenerative medicine for PD in terms of cell therapy and gene therapy are reviewed. In the end, the future direction to realize regenerative medicine for PD is discussed.
    View full abstract
    Download PDF (737K)
Original Articles
  • Selecting an Appropriate Surgical Treatment Instead of Carotid Artery Stenting Alone According to the Patient’s Risk Factors Contributes to Reduced Perioperative Complications in Patients with Internal Carotid Stenosis: A Single Institutional Retrospective Analysis
    Kimitoshi SATO, Sachio SUZUKI, Masaru YAMADA, Hidehiro OKA, Akira KURA ...
    2015 Volume 55 Issue 2 Pages 124-132
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0049
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    This retrospective study was aimed to compare the perioperative complications for internal carotid artery stenosis (ICS) in a Japanese single institute between the use of carotid artery stenting (CAS) alone or the use of an appropriate individualized treatment method allowing either carotid endarterectomy (CEA) or CAS based on patient risk factors. Based on the policy at our hospital, only CAS was performed on patients (n = 33) between January 2005 and November 2009. From December 2009 to December 2012, either CEA or CAS (tailored treatment) was selected for patients (n = 61) based on individual patient risk factors. CEA was considered the first-line treatment in all cases. In high-risk CEA cases, CAS was performed instead (n = 11), whereas in low-risk CEA cases, CEA was performed (n = 19). Further, in moderate-risk CEA cases based on own criteria, CAS was considered first, whereas for high-risk CAS cases, CEA was performed (n = 17). For low-risk CAS cases, CAS was performed (n = 9). Perioperative clinical complications (any stroke, myocardial infarction, or death within 30 days) were compared between both periods. Significantly reduced perioperative complications were observed during the tailored period (4/61 sites, 6.6%) as compared with the CAS period (8/33 sites, 24.2%) [Fisher’s exact test p = 0.022; odds ratio, 4.56 (CAS/tailored); 95% confidence interval, 1.26–16.5]. Selecting an appropriate individualized treatment method according to patient risk factors, as opposed to adhering to a single treatment approach such as CAS, may contribute to improved overall outcomes in patients with ICS.
    View full abstract
    Download PDF (916K)
  • Reappraisal of Primary Balloon Angioplasty without Stenting for Patients with Symptomatic Middle Cerebral Artery Stenosis
    Hideo OKADA, Tomoaki TERADA, Yuko TANAKA, Nagatsuki TOMURA, Kenichi KO ...
    2015 Volume 55 Issue 2 Pages 133-140
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0156
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    There is a controversy regarding the safety and efficacy of intracranial stenting. We describe our experience with primary balloon angioplasty without stenting for symptomatic middle cerebral artery (MCA) stenosis. All patients who underwent balloon angioplasty without stenting for MCA stenosis between 1996 and 2010 were retrospectively reviewed. We evaluated technical success rates, degrees of stenosis, and stroke or death within 30 days. Among patients who were followed-up for > 1 year we evaluated latest functional outcomes, stroke recurrence at 1 year, and restenosis. In total 45/47 patients (95.7%) were successfully treated. Average pre- and postprocedure stenosis rates were 79.9% and 39.5%, respectively. Three neurological complications occurred within 30 days: one thromboembolism during the procedure; one lacunar infarction; and one fatal intraparenchymal hemorrhage after the procedure. Stroke or death rate within 30 days was 6.4%. Thirty-three patients were available for follow-up analysis with a mean period of 51.5 months. The combined rate of stroke or death within 30 days and ipsilateral ischemic stroke of the followed-up patients within 1 year beyond 30 days was 9.4%. Restenosis was observed in 26.9% of patients and all remained asymptomatic. In our retrospective series, balloon angioplasty without stenting was a safe, effective modality for symptomatic MCA stenosis. For patients refractory to medical therapy, primary balloon angioplasty may offer a better supplemental treatment option.
    View full abstract
    Download PDF (614K)
  • Does Preoperative Measurement of Cerebral Blood Flow with Acetazolamide Challenge in Addition to Preoperative Measurement of Cerebral Blood Flow at the Resting State Increase the Predictive Accuracy of Development of Cerebral Hyperperfusion after Carotid Endarterectomy? Results from 500 Cases with Brain Perfusion Single-photon Emission Computed Tomography Study
    Sotaro OSHIDA, Kuniaki OGASAWARA, Hiroaki SAURA, Koji YOSHIDA, Shunro ...
    2015 Volume 55 Issue 2 Pages 141-148
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0269
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    The purpose of the present study was to determine whether preoperative measurement of cerebral blood flow (CBF) with acetazolamide in addition to preoperative measurement of CBF at the resting state increases the predictive accuracy of development of cerebral hyperperfusion after carotid endarterectomy (CEA). CBF at the resting state and cerebrovascular reactivity (CVR) to acetazolamide were quantitatively assessed using N-isopropyl-p-[123I]-iodoamphetamine (IMP)-autoradiography method with single-photon emission computed tomography (SPECT) before CEA in 500 patients with ipsilateral internal carotid artery stenosis (≥ 70%). CBF measurement using 123I-IMP SPECT was also performed immediately and 3 days after CEA. A region of interest (ROI) was automatically placed in the middle cerebral artery territory in the affected cerebral hemisphere using a three-dimensional stereotactic ROI template. Preoperative decreases in CBF at the resting state [95% confidence intervals (CIs), 0.855 to 0.967; P = 0.0023] and preoperative decreases in CVR to acetazolamide (95% CIs, 0.844 to 0.912; P < 0.0001) were significant independent predictors of post-CEA hyperperfusion. The area under the receiver operating characteristic curve for prediction of the development of post-CEA hyperperfusion was significantly greater for CVR to acetazolamide than for CBF at the resting state (difference between areas, 0.173; P < 0.0001). Sensitivity, specificity, and positive- and negative-predictive values for the prediction of the development of post-CEA hyperperfusion were significantly greater for CVR to acetazolamide than for CBF at the resting state (P < 0.05, respectively). The present study demonstrated that preoperative measurement of CBF with acetazolamide in addition to preoperative measurement of CBF at the resting state increases the predictive accuracy of the development of post-CEA hyperperfusion.
    View full abstract
    Download PDF (378K)
  • Evaluation and Management of Plaque Protrusion or Thrombus following Carotid Artery Stenting
    Naoki HASHIMURA, Tatsushi MUTOH, Kazuya MATSUDA, Keigo MATSUMOTO
    2015 Volume 55 Issue 2 Pages 149-154
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0105
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    Carotid artery stenting (CAS) has become a common treatment for carotid artery stenosis. However, complications, such as an ischemic event, can occur with CAS during intra- and post-operative periods. Among these ischemic complications, plaque protrusion into the stent and thrombus on the stent have occurred after CAS. We retrospectively evaluated the temporal profile and treatment options for these complications in 32 consecutive cases who underwent CAS at our hospital between April 2009 and December 2011. The cases were evaluated pre-operatively for risk factors, as well as the plaque morphology and characteristics using computed tomographic angiography (CTA), ultrasound (US), and magnetic resonance imaging (MRI). Post-operatively, lesions were examined by CTA and/or US within 1 week of CAS. As a result, among the 32 cases, 8 experienced plaque protrusions or thrombus, which were treated with medication (anti-platelet and/or anti-coagulation reinforcement). In 7 of these 8 cases, the plaque protrusion or thrombus was stabilized with medication alone. However, the remaining case showed growth and migration of the plaque protrusion or thrombus when treated with medication alone, and therefore, required further endovascular treatment. We identified that a history of symptomatic cerebral infarction and plaques with ulceration were risk factors for plaque protrusion or thrombus formation after CAS, and pre dilatation can decrease the risk of these complications. Medication was effective in most cases of plaque protrusion or thrombus; however, further endovascular treatment was required when medication alone was unsuccessful.
    View full abstract
    Download PDF (715K)
  • Results and Current Trends of Multimodality Treatment for Infectious Intracranial Aneurysms
    Noriaki MATSUBARA, Shigeru MIYACHI, Takashi IZUMI, Takashi YAMANOUCHI, ...
    2015 Volume 55 Issue 2 Pages 155-162
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 26, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0197
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    The authors retrospectively reviewed their cases of infectious intracranial aneurysms and discuss results and trends of current treatment modalities including medical, neurosurgical, and endovascular. Twenty patients (10 males and 10 females; mean age 46 years) with 23 infectious aneurysms were treated by various treatment modalities during a 15-year period. Fifteen cases (75.0%) were caused by infective endocarditis. Eleven aneurysms (47.8%) were ruptured. Two aneurysms (8.7%) presented a mass effect and 7 (30.4%) were unruptured and asymptomatic. The average aneurysm size was 6.5 ± 4.8 mm (range 1–22 mm). The aneurysms were located in proximal cerebral circulation in 7 (30.4%) and distal in 16 (69.6%). Six (26.1%) aneurysms were treated surgically (5: trapping, 1: neck clipping), 10 (43.5%) endovascularly (7: trapping, 2: proximal occlusion, 1: saccular coiling), and the remaining 7 (30.4%) medically. Endovascular treatment was gradually increased with time. Medical and surgical treatments were continuously performed during the study period. Surgery was preferred for the patient with intraparenchymal hematoma or treated by bypass surgery. Three periprocedural minor complications occurred in endovascular treatment. There was one postoperative infarction with permanent deficit developed from surgical treatment. During the follow-up period (mean 28.8 months), none of the aneurysms presented a recurrence or rebleeding. Thirteen patients (65.0%) had favorable clinical outcomes (modified Rankin Scale: 0–2), although four (20.0%) had poor outcomes (modified Rankin Score: 5–6). A multimodal approach for the management of infectious aneurysms achieved satisfactory results. Endovascular intervention is a feasible and efficacious treatment option and surgical intervention is still an indispensable procedure.
    View full abstract
    Download PDF (253K)
  • Efficacy and Limitations of Transarterial Acrylic Glue Embolization for Intracranial Dural Arteriovenous Fistulas
    Naoko MIYAMOTO, Isao NAITO, Tatsuya SHIMIZU, Yuhei YOSHIMOTO
    2015 Volume 55 Issue 2 Pages 163-172
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2014-0223
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    The efficacy and limitations of transarterial acrylic glue embolization for the treatment of intracranial dural arteriovenous fistulas (DAVFs) were investigated. Thirty-four DAVFs treated by transarterial embolization using n-butyl cyanoacrylate were retrospectively reviewed. The locations of DAVFs were the transverse-sigmoid sinus in 11, tentorium in 10, cranial vault in 9, and superior sagittal sinus, jugular bulb, foramen magnum, and middle cranial fossa in 1 each. Borden classification was type I in 7, type II in 3, and type III in 24. Eight patients had undergone prior transvenous coil embolization. Complete obliteration rate was 56% immediately after embolization, 71% at follow-up angiography, and 85% after additional treatments (1 transvenous embolization and 4 direct surgery). Complications occurred in three patients, consisting of asymptomatic vessel perforations during cannulation in two patients and leakage of contrast medium resulting in medullary infarction in one patient. Transarterial glue embolization is highly effective for Borden type III DAVF with direct cortical venous drainage, but has limitations for Borden type I and II DAVFs in which the affected sinus is part of the normal venous circulation. Onyx is a new liquid embolic material and is becoming the treatment of choice for DAVF. The benefits of glue embolization compared to Onyx embolization are high thrombogenicity, and relatively low risks of cranial nerve palsies and of excessive migration into the draining veins of high flow fistula. Transarterial glue embolization continues to be useful for selected patients, and complete cure can be expected in most patients with fewer complications if combined with transvenous embolization or direct surgery.
    View full abstract
    Download PDF (1232K)
  • Magnetic Resonance Imaging Findings Predict the Recurrence of Chronic Subdural Hematoma
    Haruo GOTO, Osamu ISHIKAWA, Masashi NOMURA, Kentaro TANAKA, Seiji NOMU ...
    2015 Volume 55 Issue 2 Pages 173-178
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.oa.2013-0390
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    The exact predictive factors for postoperative recurrence of chronic subdural hematoma (CSDH) are still unknown. Based on the preoperative magnetic resonance imaging (MRI), low recurrence rate of T1-hyperintensity hematoma was previously reported. We investigated the other types of radiological findings which are related to the recurrence rate of CSDH in large number of patients analyzed by multivariate logistic regression model. Preoperative MRI and postoperative computed tomography (CT) were performed and the influence of the preoperative use of antiplatelet or anticoagulant drugs was also studied. The overall recurrence rate was 9.3% (47 of 505 hematomas). The MRI T1-iso/hypointensity group showed a significantly higher recurrence rate (18.2%, 29 of 159) compared to the other groups (5.2%, 18 of 346; p < 0.001). Multivariate logistic regression analysis showed T1 classification was the solo significant prognostic predictor among various factors such as bilateral hematoma, antiplatelet or anticoagulant drug usage, residual hematoma on postoperative CT, and MRI classification (p < 0.001): adjusted odds ratio for the recurrence in T1-iso/hypointensity group relative to the T1-hyperintensity group was 5.58 [95% confidence interval (CI), 2.09–14.86] (p = 0.001). Postoperative residual hematoma and antiplatelet or anticoagulant drug usage did not increase the recurrence risk. The preoperative MRI findings, especially T1WI findings, have predictive value for postoperative recurrence of CSDH and the T1-iso/hypointensity group can be assumed to be a high recurrence risk group.
    View full abstract
    Download PDF (455K)
Case Reports
  • Posttraumatic Cerebellar Infarction after Repeated Sport-related Minor Head Injuries in a Young Adult: A Case Report
    Hiroaki MATSUMOTO, Yasuhisa YOSHIDA
    2015 Volume 55 Issue 2 Pages 179-182
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: January 23, 2015
    DOIhttps://doi.org/10.2176/nmc.cr.2014-0094
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    A healthy 23-year-old man suffered helmet-to-helmet collisions with an opponent during American football game twice within 3 days. He then experienced continuous vomiting and dizziness. Magnetic resonance imaging revealed acute infarction in the right cerebellar hemisphere, and magnetic resonance angiography revealed transient stenosis of the right superior cerebellar artery. Although minor head injury is not usually accompanied by complications, posttraumatic ischemic stroke has been reported on rare occasions. We report a case of cerebellar infarction after repeated sports-related minor head injuries in a young adult and discuss the etiology.
    View full abstract
    Download PDF (1170K)
  • Simultaneous Bilateral Stenosis of the Vertebral Arteries Treated by Unilateral Decompression: A Case Report
    Jin Hoon PARK, Seung Hoon YOU, Sung Woo ROH, In Seok HWANG, Sang-Youl ...
    2015 Volume 55 Issue 2 Pages 183-187
    Published: 2015
    Released on J-STAGE: February 15, 2015
    Advance online publication: December 27, 2013
    DOIhttps://doi.org/10.2176/nmc.cr.2013-0094
    JOURNAL OPEN ACCESS
    Show abstractHide abstract
    A 56-year-old man presented with a 3-month history of progressive dizziness. His dizziness was aggravated when his head was rotated to the right side. Diagnostic angiography showed that a normal right-sided vertebral artery in the neutral position became an abnormal vertebral artery with two stenotic lesions at the C3–4 and C5–6 levels when the patient’s head was turned to the right. A normal left-sided vertebral artery also showed a stenotic lesion at the C2 level when the patient’s head was turned right. The axialdimensions of the bilateral vertebral arteries were similar. The patient was successfully treated withdecompression of only one level (C5–6). We conclude that if a bilateral stenosis is found upon one directional head rotation and the bilateral vertebral arteries are similarly sized, a one-sided treatment may suffice.
    View full abstract
    Download PDF (1126K)
Editorial Committee
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top